Nearly 1 million Alu elements in human DNA were inserted by an RNA-mediated retroposition-amplification process that clearly decelerated about 30 million years ago. Since then, Alu sequences have proliferated at a lower rate, including within the human genome, in which Alu mobility continues to generate genetic variability. Initially derived from 7SL RNA of the signal recognition particle (SRP), Alu became a dominant retroposon while retaining secondary structures found in 7SL RNA. We previously identified a human Alu RNA-binding protein as a homolog of the 14-kDa Alu-specific protein of SRP and have shown that its expression is associated with accumulation of 3-processed Alu RNA. Here, we show that in early anthropoids, the gene encoding SRP14 Alu RNA-binding protein was duplicated and that SRP14-homologous sequences currently reside on different human chromosomes. In anthropoids, the active SRP14 gene acquired a GCA trinucleotide repeat in its 3-coding region that produces SRP14 polypeptides with extended C-terminal tails. A C3G substitution in this region converted the mouse sequence CCA GCA to GCA GCA in prosimians, which presumably predisposed this locus to GCA expansion in anthropoids and provides a model for other triplet expansions. Moreover, the presence of the trinucleotide repeat in SRP14 DNA and the corresponding C-terminal tail in SRP14 are associated with a significant increase in SRP14 polypeptide and Alu RNA-binding activity. These genetic events occurred during the period in which an acceleration in Alu retroposition was followed by a sharp deceleration, suggesting that Alu repeats coevolved with C-terminal variants of SRP14 in higher primates.
Ample evidence indicates that amplification of short interspersed elements (SINEs) occurred via reverse transcription of small RNA intermediaries in a process termed retroposition (52) . The SINEs of many organisms are related to one or another tRNA, and these have been found widely distributed in nature, including in plants, fish, and mammals (see references 13, 43, and 44 and references therein). The Alu family of SINEs was derived from the terminal portions of the 7SL RNA component of the signal recognition particle (SRP), a small ribonucleoprotein involved in intracellular protein trafficking (6, 24, 27, 70, 71, 74, 77) . In contrast to tRNA-like SINEs, and despite the ubiquity of 7SL SRP RNAs, Alu-related SINEs are for unknown reasons mostly limited to rodents and primates (for a recent review, see reference 13).
Evolution of Alu-related SINEs apparently occurred in two major phases: an ancient period during which Alu sequences emerged as monomeric elements followed by a period of remodelling and proliferation (see reference 50 and references therein). The discovery of fossil Alu sequences provided evidence that an Alu monomer originated in an ancestor common to rodents and primates (50) . The monomeric Alu-equivalent SINE referred to as B1 has since undergone substantial divergence from 7SL during its amplification to ϳ50,000 to 80,000 copies per haploid genome in rodents (3, 29) . Trace levels of ancient Alu monomers have also been identified in primate DNA; however, these are no longer active (26, 28, 48, 49) . In early primates, Alu monomers underwent modest divergence from 7SL and were remodeled into a dimeric element of great transpositional potential while preserving 7SL RNA secondary structures in each monomer (26, 31, 56, 62) . However, although the dimeric Alu structure appeared in the earliest primates, its amplification rate has been significantly lower in prosimians than in simians (anthropoids) (11, 12) . Furthermore, while rodent and prosimian genomes amplified 7SL-related SINEs in addition to tRNA-related SINEs, simian genomes expanded only one dominant SINE, i.e., Alu (3, 11, 13) .
Classification of Alu repeats into subfamilies of distinctive evolutionary ages in conjunction with examination of Alu sequences in several primate genomes has revealed a more detailed temporal image of the Alu amplification pattern in primates (6, 12, 27, 47, 57, 64, 78) . Alu proliferation in prosimian primates appears to have occurred in that isolated lineage since (i) galago (prosimian) Alu sequences are diagnostically different from anthropoid Alus (12) and (ii) individual Alu repeats common to anthropoid genomes cannot be found at the orthologous loci in prosimians (55, 57, 59) . These studies indicate that a dimeric founder Alu existed in the earliest primate genome but that it subsequently amplified to different extents and evolved along different pathways in prosimian and simian genomes. In the simian lineage, Alu elements underwent a concentrated amplification that was specific to early anthropoids. Thus, by 30 to 50 million years ago, the great majority of Alu repeats to be ultimately inherited by the human genome were amplified de novo in early anthropoid DNA, and the rate of amplification slowed dramatically thereafter (5) (6) (7) 12 ; reviewed in references 57 and 59) .
While relatively few Alu sequences continue to transpose in humans, a substantial fraction of these have caused genetic variability and/or gene disruptions that have come to the at-tention of geneticists (1, 14, 22, 25, 39, 42, 54, 73) . Further characterization of human-specific Alu sequences has allowed the calculation of an Alu de novo transposition rate of 1 in 100 human births (13) . Yet despite their effects on the human genome and the existence of an insightful model of retroposition (23, 72) , much remains unknown about factors which facilitate Alu mobility (58) .
Conservation of 7SL RNA-like secondary structures in transcripts of active Alu and B1 sequences suggests a function related to SRP (6, 33, 34, 40, 62, 63) . However, such conservation also suggests that these RNA structures may simply stabilize Alu RNA or provide recognition by the Alu retroposition machinery (9, 30, 31, 33, 62, 63) . Recent advances in detecting cellular Alu and B1 transcripts has provided new impetus to their study and a better understanding of their regulation in human cells (9, 10, 15, 32, 33, 35-37, 40, 45, 53, 63) . Under basal conditions, a small fraction of Alu elements are transcribed by RNA polymerase III to produce poly(A) ϩ -containing nascent transcripts, whereas Alu transcription increases dramatically in response to viral infection (10, 36, 40, 45, 46, 53, 63) . A subset of these Alu nascent transcripts are thought to represent transposition intermediaries.
According to the current model of Alu retroposition, the 3Ј terminal oligo(U) residues produced as a result of termination by polymerase III intramolecularly base pair with the internal poly(A) tract to provide a self-primed template for reverse transcriptase (23, 41 ; for reviews, see references 13 and 56). The discovery of an Alu left monomer RNA (40) led to the suggestion that some nascent Alu transcripts can be diverted from the transposition pathway by conversion to poly(A) Ϫ transcripts known as small cytoplasmic Alu (scAlu) RNA (9, 10, 36, 40) . Such 3Ј processing would reduce the potential of Alu primary transcripts for retroposition by decreasing the likelihood of generating a full-length reverse cDNA. Thus, on the basis of 7SL-like RNA structure conservation and several lines of experimental evidence, researchers have proposed that posttranscriptional mechanisms of Alu RNA expression may constitute important determinants of Alu mobility and evolution (13, 26, 31, 33, 35-37, 56, 63) .
The Alu-homologous region of 7SL RNA is associated with two SRP polypeptides with molecular masses of 9 and 14 kDa which together form a stable heterodimer known as SRP9/14 (4, 18, 60, 65, 67, 68, 75) . The human SRP14 gene produces a protein of ϳ18 kDa because of a trinucleotide repeat-containing region (TCR) in the 3Ј-coding sequence of its mRNA (10) . This ϳ18-kDa SRP14 protein interacts with Alu sequence RNA efficiently in vitro (10) . The ϳ18-kDa human SRP14 protein is overexpressed relative to the corresponding endogenous rodent protein in somatic cell hybrids (10) .
Overexpression of human SRP14 in these cells is reflected by increased Alu RNA-binding activity, and this leads to accumulation of scAlu RNA at the apparent expense of Alu nascent transcripts, suggesting a direct role in Alu RNA metabolism (10) . The evolutionary conservation of 7SL RNA secondary structure by active Alu sequences in conjunction with these observations indicates that primate SRP14 is a candidate factor involved in Alu expression and evolution (10) . Here, we examine the relationship between the origin of the TCR in primate SRP14 genes and the expression of SRP14-mediated Alu RNA-binding activity in primate cells for which Alu evolution has been previously characterized. Western blot (immunoblot) analysis. Whole-cell extracts were prepared as previously described (10) . Protein contents were determined by the Bio-Rad colorimetric protein assay and confirmed by side-by-side comparison of Coomassie blue-stained sodium dodecyl sulfate (SDS)-polyacrylamide gels (not shown). Rabbits were immunized with a synthetic peptide consisting of amino acids 5 to 19 of SRP14; the amino acid sequence of this peptide is 100% identical in mouse and human SRP14 (10, 66) . Antibodies were affinity purified on SRP14-glutathione-S-transferase (GST)-glutathione-Sepharose by using recombinant human GST-SRP14 as follows. A 200-l volume of antiserum was incubated with 50 l of GST-SRP14-Sepharose for 2 h at room temperature and washed with 1 ml of 50 mM Tris-Cl (pH 8.0)-0.15 M NaCl-1 mM EDTA-0.05% Nonidet P-40 six times. Antibodies were then eluted with 0.2 M glycine (pH 2.8), neutralized with Tris base, and stabilized with albumin. Whole-cell extracts were fractionated by SDS-polyacrylamide gel electrophoresis (PAGE) (18%) and were transferred to nitrocellulose. After blocking, blots were incubated with affinity-purified anti-SRP14-peptide antibody, washed, and developed with the enhanced chemiluminescence kit from Amersham according to the manufacturer's instructions.
MATERIALS AND METHODS
Alu RNA-binding activity. Electrophoretic mobility shift analysis (EMSA) using whole-cell extracts was as previously described (9, 10) . EMSA results were quantitated with a PhosphorImager (Molecular Dynamics). For reliable detection and quantitation, it was necessary to use more total protein from galago and NIH 3T3 whole-cell extract than from other cell lines; however, EMSAs performed at various protein concentrations and poly(rG) (nonspecific inhibitor) concentrations yielded similar results.
PCR analysis of the 3 TCR of the SRP14 gene. DNA was purified from cultured cells by overnight treatment with SDS-proteinase K and then by phenolchloroform extraction, ethanol precipitation, and solubilization in Tris-EDTA buffer. After boiling, DNA was added to PCR components, which were preheated to 80ЊC, and cycling was begun immediately thereafter. PCR parameters were 94ЊC for 40 s, 55ЊC for 30 s, and 72ЊC for 30 s, for a total of 40 cycles (see the legend to Fig. 3A for positions of primers). Aliquots were analyzed by 3% agarose gel electrophoresis-ethidium bromide staining-UV visualization. PCR products were gel purified and used as templates for direct sequencing by using the PCR-based fmol sequencing kit from Promega. For PCR from somatic cell hybrids, purified DNA samples were provided by the Corriell Institute for Medical Research (21). PCR was as described above, except that the cycling parameters were 94ЊC for 40 s, 60ЊC for 30 s, and 72ЊC for 30 s, for a total of 40 cycles (see the legend to Fig. 3B for positions of primers).
Southern blot analysis. Purified DNA (10 g) was incubated with restriction enzymes (50 Units; New England Biolabs) overnight and fractionated through 0.7% agarose, briefly acid depurinated, and transferred to a nylon membrane (GeneScreen Plus; Dupont), all by standard methods. The membranes were incubated with hybridization solution containing 5ϫ SSPE (1ϫ SSPE is 0.18 M NaCl, 10 mM NaPO 4 , and 1 mM EDTA [pH 7.7]), 0.1% SDS, 5ϫ Denhardt's solution, and 100 g of salmon sperm DNA per ml. After a 2-h prehybridization period, boiled probe was added, and hybridization proceeded at 60ЊC for 16 h. Probe was generated by random priming in the presence of [␣- 32 P]dCTP of the first 305 bp of the SRP14 Alu RBP cDNA by standard procedures (10) . The blots were washed nonstringently at 60ЊC with 1ϫ SSPE-10% SDS for 2 h and were then washed with 1ϫ SSPE-0.1% SDS for 1 h and were visualized by autoradiography.
RESULTS
Anthropoid-specific expression of SRP14 polypeptide correlates with elevated levels of Alu RNA-binding activity. Figure 1 shows a Western blot of the SRP14-homologous proteins isolated from cultured cells derived from various species. The antibody used was raised against a synthetic peptide located close to the N terminus whose amino acid sequence is 100% identical in mice and humans (10, 66) . As expected, the antibodies detected an ϳ18-kDa polypeptide from HeLa wholecell extract (Fig. 1A , lane 1) which comigrated with highly purified ϳ18-kDa SRP14 (previously described as a component of Alu RNA-binding protein [RBP]) (10) (Fig. 1A , lane 2). Also as expected, these antibodies detected polypeptides of ϳ14 kDa in mice (NIH 3T3) and galagos (prosimian) (Fig. 1B , lanes 4 and 5), whereas all subsequently evolved primates examined exhibited proteins with larger sizes (lanes 1 to 3). The owl (New World) monkey protein, with an apparent mass of ϳ28 kDa, is the largest of these (Fig. 1B, lane 3) , while the green (Old World) monkey protein migrates at ϳ20 kDa (lane 2). Orangutan, gorilla, and chimpanzee cells also expressed an ϳ18-kDa protein, while baboon cells expressed a protein whose mobility was indistinguishable from that of the green monkey protein (data not shown). Thus, all anthropoid cells examined expressed a larger SRP14 than did other mammals. As will be shown below, this is due to variation in the 3Ј-coding TCR. Similar results were obtained from multiple extract preparations; in all cases, the amounts of SRP14 polypeptide from galago and NIH 3T3 cells were significantly less than those from anthropoid extracts. More protein was loaded in Fig. 1B , lanes 4 and 5, than in lanes 1 to 3 (see Fig. 1 legend) , as determined by a colorimetric assay and SDS-PAGE-Coomassie staining (data not shown [but see Fig. 1C ]). The antibodies used were directed to a peptide sequence that was 100% conserved from mice to humans. These antibodies detected comparable amounts of galago, mouse, and human SRP14 proteins when SRP was first enriched by immunoprecipitation with a constant amount of anti-SRP54 serum (data not shown), further indicating that they can recognize SRP14 comparably from these species. Thus, in addition to the size differences, the affinity-purified anti-SRP14-peptide antibodies consistently detected more SRP14 polypeptide in whole-cell extracts of anthropoid primate cells than they did in rodent and prosimian cell extracts. As will be shown below, the increased amounts of SRP14 polypeptide in anthropoid cells are reflected by increased amounts of Alu RNA binding activity in the same extracts.
As indicated above and in the legend to Fig. 1B , we analyzed more protein from mouse and galago extracts than from simians because we reproducibly detected less SRP14 per microgram of protein in rodent and prosimian cell extracts (Materials and Methods). Figure 1C shows the results of Western analysis with antiserum that recognizes a ubiquitous ϳ50-kDa RBP, La, which is involved in transcription termination by RNA polymerase III (17, 37) . These results demonstrated that as expected, the lanes containing NIH 3T3 and galago samples contained more La antigen, which reflected the greater amount of protein loaded. Thus, on the basis of these results in conjunction with those in Fig. 1B , we conclude that simian cells contain more SRP14 polypeptide than do other mammals, including prosimians.
In order to evaluate the relative amounts of SRP in these extracts, we examined 7SL RNA by Northern (RNA) blot analysis. The 7SL RNA subunit of SRP is efficiently contained in SRP and therefore should reflect SRP levels (76) . Total RNA was prepared from aliquots of the whole-cell extracts used above; each aliquot contained an equal amount of total protein. The RNA was fractionated by denaturing PAGE, transferred to a nylon membrane, and hybridized with an oligonucleotide probe complementary to a region of 7SL RNA that is 100% identical in rodents and humans (51) (Fig. 1D , upper panel). This procedure revealed comparable amounts of 7SL RNA in NIH 3T3, galago, owl monkey, and green monkey cell extracts and smaller amounts of this RNA in HeLa extracts (see the legend to Fig. 1 ). The relatively small amount of 7SL RNA in HeLa extracts was significant, as was seen by reprobing this blot with an oligonucleotide complementary to 5S rRNA (Fig. 1D, lower panel) . These results suggest among other things that the ratio of SRP to ribosomes is lower in HeLa cells than in the other cells examined. Cumulatively, the results shown in Fig. 1 suggest that 7SL RNA and SRP14 Alu RBP subunits are not coordinately regulated to the same extent in these cells and that the ratio of SRP14 to its ligand, 7SL RNA, is specifically increased in anthropoids relative to other mammals, including prosimians.
The size difference between rodent and human SRP14 Alu RBPs is apparent in the Alu RNA-mediated EMSA (9, 10) . Figure 2A shows that the mobilities of Alu RNA-protein complexes formed from the various extracts used above reflected the mobility profile expected on the basis of Western analysis. Furthermore, as was anticipated from the results of Fig. 1 , anthropoid primate cell extracts ( Fig. 2A, lanes 1 to 3) consistently exhibited more Alu RNA binding activity per microgram of total cell protein than did the other species (lanes 4 and 5), as quantitated for Fig. 2B . Human fetal fibroblast, human hepatoma, chimpanzee, gorilla, orangutan, and baboon cell extracts all produced an RNA-protein complex that was indistinguishable in mobility from that of HeLa cells, and all of these contained high levels of Alu RNA-binding activity that were similar to that of HeLa cells, whereas lemur cell (pro- Variable-length GCA repeat-containing region in anthropoid SRP14 genes. Human (ϳ18-kDa) SRP14 Alu RBP is larger than those reported for mouse and dog cells because it contains a 28-residue, alanine-rich, C-terminal tail which is translated from a 3Ј GCA-rich TCR (10, 66) . In order to determine whether variability in the 3Ј TCR lengths accounted for the size difference between the SRP14-homologous proteins, we used primers which flank the human TCR to amplify genomic DNAs from various primate species by PCR. As predicted from the mouse SRP14 cDNA sequence, this PCR assay would not be expected to amplify mouse DNA (10, 66) . The expected band of 194 bp was readily amplified from human DNA (Fig. 3A, lane 1) , in addition to an unexpected band of ϳ120 bp (see below). Direct sequencing of the larger PCR band from human DNA revealed that it was the ϳ18-kDa SRP14 3Ј-coding region containing the TCR (10) ( Table 1) . Using these primers, we could amplify products with variable sizes from the genomic DNAs from owl monkey, green monkey, orangutan, gorilla, and chimpanzee cells (Fig. 3A) . In each case, the size of the larger PCR fragment was consistent with the size of the SRP14 Alu RBPs detected by Western blots and EMSAs. Sequence analyses of these PCR products confirmed, in all cases examined (owl monkey, green monkey, chimpanzee, and human cells), the presence of an expanded 3Ј TCR flanked by SRP14 sequences, as summarized in Table 1 . Trinucleotide repeats are known to be genetically unstable, leading to repeat length hypervariability in genes which have been identified by their association with specific diseases (8, 16) . Therefore, we examined genomic DNAs from many different humans, five additional chimps, two gorillas, and three additional orangutans. Surprisingly, we could not detect intraspe-
FIG. 2. SRP14-mediated
Alu RNA-binding activity is increased in anthropoids. (A) EMSA for 32 P-labeled Alu RNA binding using whole-cell extracts. Mobility of free RNA probe is indicated. For the purpose of reliable detection and quantitation, reaction mixtures in lanes 1 to 3 contained 1 g of whole-cell extract, while lanes 4 and 5 contained 5 g of whole-cell extract (see Materials and Methods). (B) Specific activity of Alu RBP expressed as femtomoles of RNA specifically shifted per microgram of protein as previously described (10) . Means and standard deviations were calculated and plotted on the basis of three independent experiments; however, for any given experiment, HeLa, green monkey (Gr. monk), and owl monkey (Owl monk) extracts each exhibited at least 8.5-fold higher RNA-binding activity than galago and NIH 3T3 extracts. (10) . The identities of cell lines are indicated above the lanes. IMR91 is male DNA representing the entire human genome, GM11418 contains chromosome 15 as its only human chromosome, GM10927A contains chromosome 11 as its only human chromosome, GM10500 contains a single rearranged human chromosome in which a portion of the q arm of chromosome 17 has been translocated to a fragment of chromosome 15, GM10659 contains chromosomes 15 and 11 in addition to other human chromosomes, and GM00932 contains human chromosome 11 in addition to other chromosomes but does not contain human chromosome 15 (10, 21 cies size variability by our PCR assay, although slight size variability might be detectable by a more sensitive assay (not shown). In any case, the size differences of different primate species' SRP14 proteins are due to corresponding size differences in the translated 3Ј TCR encoded by their genomic DNAs.
As evidenced in Fig. 1 and 2 , the size of galago SRP14 is similar to those reported for rodent and dog SRPs (10, 66) , which therefore suggests that it is expressed from a gene which does not contain a TCR. As such, the PCR primers used would be expected to amplify a galago-derived fragment of ϳ120 bp, precisely the size of the single PCR product seen after amplification of galago DNA (Fig. 3A, lane 7) . A single PCR product identical in size to the single galago product was also readily produced from lemur DNA (data not shown). Direct sequencing of the galago PCR product confirmed that it encoded the SRP14 C-terminal region and that it lacked an expanded TCR (Table 1) . However, it is noteworthy here that while the relevant sequence of mouse SRP14 cDNA in this region is CCA GCA (66) (Table 1) , the galago sequence and those of all primates examined harbor the sequence GCA GCA in this region (substitution codon in Table 1 ), suggesting that the C3G base substitution which fortuitously generated two consecutive GCA codons in the prosimian galago facilitated GCA expansion in later primates.
The SRP14 gene is duplicated in anthropoids. A second, smaller PCR product amplified from human and other primate DNAs is similar to the galago band of ϳ120 bp (Fig. 3A) . These results suggested that anthropoids contain two SRP14-homologous sequences, one with an expanded TCR and the other more similar to those of galagos and lemurs. Each of four different primer pairs which flank the TCR amplified two different products from human and other primate DNAs, a larger one containing a TCR and a smaller one more similar to those of galagos and lemurs, while none of these primer pairs produced a larger band in galago or lemur DNA (not shown). The smaller PCR bands exhibited slight size variations in the different primates tested (Fig. 3A) . Direct sequencing of the smaller band from human DNA revealed it to be identical to the larger SRP14 sequence but containing eight GCA trinucleotide repeats in the region occupied by 28 codons in the ϳ18-kDa SRP14-encoding DNA (10) (not shown). Likewise, the sequences of the smaller bands from chimpanzees and green monkeys revealed SRP14 homologs with five and two GCA triplets, respectively (not shown). Thus, TCR length variability accounts for the size variation of the larger and smaller PCR products in primate genomes. These data suggest that two SRP14-homologous sequences reside in the genomes of anthropoids; this was corroborated by Southern blotting and by demonstrating that each of the two PCR-amplified human SRP14-homologous sequences resides on a distinct chromosome.
We previously demonstrated using rodent ϫ human somatic cell hybrids (SCH) that an active gene encoding the human ϳ18-kDa SRP14 Alu RBP resides on human chromosome 15 at 15q22 (10) . We assumed that this gene served as a template for the larger of the two PCR products amplified from human DNA (Fig. 3A) on the basis of the sequence of the PCR product and because a product of the same size was amplified when human ϳ18-kDa SRP14 cDNA was used as a template (not shown). Figure 3B demonstrates the chromosomal origins of the two human SRP14-related PCR products using DNA from well-characterized SCH which contain different human chromosomes (21) . As expected, the larger PCR product was amplified from GM11418, a SCH which contains chromosome 15 as its only human chromosome (Fig. 3B, lane 2) (10, 21) . By contrast, the smaller PCR product was not amplified from this SCH (lane 2). Another monochromosomal hybrid, GM10500, which contains chromosome 15, also served as a template for the amplification of the larger PCR product but not for that of the smaller (Fig. 3B, lane 4) . Pilot experiments using multiple SCH indicated that the smaller band was encoded by chromosome 11. This was confirmed by demonstrating that the smaller PCR product could be amplified from SCH GM10927A, which contains chromosome 11 as its only human chromosome (21) , whereas the larger PCR product was not amplified from this SCH (Fig. 3B, lane 3) . The smaller PCR product could be amplified from other SCH which contain human chromosome 11 (lanes 5 and 6). SCH GM10659, which contains both chromosomes 11 and 15, served as a template for both PCR products (lane 5). Therefore, at least two SRP14-homologous sequences exist in the human genome, and these currently reside on different chromosomes.
Previous Southern blot analysis identified a single band representing the SRP14 sequence in rodents, multiple bands from total human DNA, and a single band from human chromosome 15 (see Fig. 6 a Dots indicate identity with the galago sequence; differences are indicated directly above by the base.
b In human SRP14 cDNA, this TCR region contains mostly (nineteen) GCA triplets, but is also rich in ACA repeats (10) . Owl monkey and green monkey TCRs contain GCA triplets in the same relative proportions as that in the human sequence (not shown).
c The nucleotide position which, substituted in galagos, constitutes two adjacent GCA codons which are immediately 3Ј to the expanded GCA-rich TCR in anthropoids; in mice, this CCA codon encodes proline, whereas the corresponding GCA codon in humans encodes alanine (10, 66 
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Southern blot analysis of primate DNAs (Fig. 4) . Several restriction enzymes each yielded a multiplicity of bands in owl monkey (anthropoid [New World]) DNA compared with galago (prosimian) DNA (Fig. 4) . Although galago DNA produced two or three bands with some enzymes (Fig. 4 , lanes 1, 2, and 5), other enzymes produced a single band (lanes 3 and 4). By contrast, each enzyme produced at least twice as many bands from owl monkey DNA (Fig. 4 , lanes 6 to 10) as from galago DNA (lanes 1 to 5). All other anthropoids examined revealed a multiplicity of bands with a complexity similar to that seen with owl monkey and human DNA (not shown). These results are consistent with the contention that the prosimian galago contains a single SRP14 gene, while later primates contain more than one SRP14-homologous sequence. It was previously shown that the human gene represented by a single ϳ3.3-kbp PstI fragment from chromosome 15q22 actively produces the ϳ18-kDa SRP14 Alu RBP (10). The SRP14-homologous sequence which resides on chromosome 11 may not be active, since the expected protein of ϳ14 kDa was not observed, although low amounts might not be detectable by our assays ( Fig. 1 and 2A ).
DISCUSSION
The major conclusion that can be drawn from this study is that several genetic events affected the SRP14 gene during early primate evolution. These included gene duplication, origin and expansion of a TCR in the 3Ј-coding sequence of the active SRP14 gene, and increased expression. The net result was the creation of an overexpressed variant of the SRP14 Alu RBP in anthropoids. Cumulatively, the data presented here are consistent with previous results which demonstrated that rodent ϫ human SCH expressed substantially more human-specific Alu RBP activity than the endogenous rodent-specific RBP activity expressed in the same cells (10) . Western blots of such hybrid cells reveal correspondingly more human SRP14 than rodent SRP14, providing further support of the interpretation that greater accumulation of human SRP14 accounts for a higher level of RNA-binding activity (17a) . An additional conclusion drawn from Fig. 1 and 2 is that the ratio of SRP14 (and its RNA-binding activity) to its ligand 7SL RNA is substantially increased in anthropoid cells.
The modifications of the SRP14 gene that are associated with increased levels of Alu RNA-binding activity occurred during the evolutionary period that encompassed the major amplification of Alu elements and therefore suggest that Alu RBP influenced Alu expansion in anthropoids (5) (Fig. 5) . However, we wish to emphasize that although these results demonstrate a correlation among the origin of a TCR, increased expression of SRP14, and the major wave of Alu amplification in primates, they do not prove a cause and effect relationship. At the present time, we do not know if the putative effect of SRP14 on Alu expression was positive or negative in early anthropoids. For example, we do not know if the multiple genetic events that affected SRP14 occurred simultaneously or as discrete events; nor do we know the temporal order of these events in relation to the acceleration and deceleration in the amplification rates that shaped the wave of Alu expansion. In any case, we suspect that determinants such as evolution of the Alu nucleotide sequence itself and the effects of such changes on the ability of Alu sequences to interact with the transposition machinery contributed significantly to shaping the complex pattern of Alu amplification during primate evolution. It is hoped that future investigations will resolve some of these relationships and address more precisely the nature of the correlations presented here. Human ϳ18-kDa SRP14 Alu RBP can interact with Alu RNA in vitro (9) and affect Alu RNA levels in vivo (10) . It was previously shown that chromosome 15-containing, Alu RBPexpressing, SCH contain an abundance of processed scAlu RNA but much less nascent Alu RNA, while this ratio was reversed in Alu RNA-expressing SCH which do not express Alu RBP (see Fig. 3A of reference 36) . Thus, overexpression of human ϳ18-kDa SRP14 Alu RBP led to accumulation of processed scAlu RNAs, presumably at the expense of nascent Alu intermediary transcripts (10) . This suggests that increased levels of SRP14 may directly affect Alu RNA metabolism. As noted in the introduction, 3Ј processing of nascent Alu transcripts would be expected to decrease the potential of an Alu transcript for retroposition. On the basis of these observations, we are compelled to consider the possibility that the genetic events which led to increased expression of SRP14 were selected for as a result of a negative effect on a high rate of Alu mobility. The Alu amplification rate was about 100-fold greater in early anthropoids than in humans (5, 13, 59) . In this scenario, anthropoid-specific SRP14 would have evolved as a factor whose increased expression would limit Alu expansion.
We should also consider an alternative interpretation of the relationship between primate SRP14 and Alu expansion. Once Alu elements amplified, many would be transcribed as part of heterogeneous nuclear RNAs (hnRNAs) and mRNAs. Such interspersed Alu dimeric RNA elements, each representing two SRP9-SRP14-binding sites, might confer a formidable burden on the level of free SRP9/14 that was available to bind 7SL RNA. The level of SRP9/14 Alu RBP would have to increase to meet the demand. According to this model, the increase in Alu RBP levels in primates would have been due to pressure exerted by Alu amplification, and selection for increased expression of SRP14 would facilitate rather than limit Alu amplification. In this model, increases in SRP14 Alu RBP would be a response to Alu amplification but would not have been involved in the amplification process per se. Recent results are consistent with either model. The Alu-homologous region of 7SL RNA facilitates its nucleocytoplasmic transport, possibly via interaction with SRP9/14, suggesting that the latter is a nuclear protein (19) . Thus, SRP9/14 Alu RBP may have access to large amounts of hnRNA and mRNA. Alu RBP can indeed recognize and bind to Alu sequences embedded within larger transcripts such as mRNAs (20) . In light of these observations, FIG. 5 . Phylogenetic tree showing relationships among the primate species represented in this study, their SRP14 TCR lengths (see Table 1 ), and their levels of SRP14 expression. ϩ, normal; ϩϩϩ, high. The broken horizontal line separates prosimians (above) and anthropoids (below). NWM, New World monkey; OWM, Old World monkey; Afr Grn Mky, African green monkey. The upper horizontal line indicates the time scale in millions of years (myr) before the present. Approximately 85% of the Alus in human DNA were inserted by the time New World monkeys split from the anthropoid lineage about 35 million years ago; the majority of the remaining Alus were inserted over the subsequent 10 million years, with only ϳ0.5% inserted in the last 8 million years. Thus, there exists a correlation between Alu insertion rates and trinucleotide repeat (TNR) lengths. The tree is a composite modified from references 38 and 59. it is difficult to imagine how the amount of Alu RNA contained in hnRNA and mRNA could have appeared in primate cells without having an impact on the integrity of SRP structure and perhaps function unless compensatory elevations in Alu RBP also occurred.
With the above considerations in mind, it is reasonable to suggest that the Alu sequences in human DNA and the genetic alterations in SRP14 Alu RBP coevolved in early anthropoids. The idea that this may have been attributable to a C3G substitution that predisposed the SRP14 locus to GCA triplet expansion and aberrant expression is intriguing and may provide a model not only for triplet expansions in other genes but for coevolution of genetic elements in complex biological systems as well.
The data reported here suggest that the evolutionary modifications of SRP14 have implications for human cell biology. The results represented by Fig. 1 suggest that individual subunits of SRP need not be tightly regulated in cultured cells. It is possible that the extended structure of primate-specific SRP14 facilitates dissociation of SRP9/14 from SRP; what effects, if any, the primate-specific C-terminal tail may have on SRP assembly or function have yet to be examined. Through such investigations, we may learn, among other things, whether the recently developed C-terminal tail of SRP14 enhanced, impaired, or remained neutral with respect to SRP function in primate cells and may provide insight into the idea that primate SRP14 evolution might have occurred for reasons other than those directly related to SRP (i.e., related to Alu amplification).
SRP9/14 together with the Alu-homologous region of 7SL RNA confers translational control on a subset of mRNAs (60, 61, 65, 67) . SRP9/14 Alu RBP binding sites in the form of Alu sequences in pre-mRNAs as well as many mature mRNAs suggest the possibility that Alu RBP affects the metabolism or translatability of these RNAs in primates (10) . Finally, we must also consider the possibility that primate-specific Alu-homologous transcripts such as scAlu RNA, full-length Alu transcripts, and neuron-specific BC200 RNA (9, 36, 40, 45, 63, 69) , in conjunction with SRP9/14 Alu RBP, mediate novel forms of translational control in a manner similar to that of the SRP9/ 14-mediated elongation arrest domain of SRP.
